ð°ñð´ð¸ñ - Open Access .click

Results 51 to 60 of about 5,541,240 (260)

The Role of Nurse in Macedonian Bank for Human DNA [PDF]

, 2015
ÐžÐ¡ÐÐžÐ’Ð: Ð‘Ð°Ð½ÐºÐ° Ð·Ð° Ñ…ÑƒÐ¼Ð°Ð½Ð° Ð”ÐÐš (Ñ…Ð”ÐÐÐœÐšÐ”) Ð¿Ñ€ÐµÑ‚ÑÑ‚Ð°Ð²ÑƒÐ²Ð° ÑÐºÐ»Ð°Ð´Ð¸Ñ€Ð°ÑšÐµ Ð½Ð° Ð¿Ñ€Ð¸Ð¼ÐµÑ€Ð¾Ðº Ð½Ð° Ð”ÐÐš Ð¾Ð´ Ð¿Ð¾ÐµÐ´Ð¸Ð½ÐµÑ†Ð¾Ñ‚, ÐºÐ°ÐºÐ¾ Ð¸ Ð½ÐµÑ˜Ð·Ð¸Ð½Ð¾ Ð±ÐµÐ·Ð±ÐµÐ´Ð½Ð¾ Ð¸ Ð´Ð¾Ð»Ð³Ð¾Ñ€Ð¾Ñ‡Ð½Ð¾ Ñ‡ÑƒÐ²Ð°ÑšÐµ ÑÐ¾ Ñ†ÐµÐ»
Cvetkovska, Elena, Spiroski, Mirko
core +2 more sources

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen +13 more
wiley +1 more source

, 2016
Ð¸Ð·Ð²Ð°Ð ...
Ð¸Ð½Ñ„Ð¾Ñ€Ð¼Ð°Ñ‚Ð¸ÐºÐ°, ÐœÐ•Ð”Ð˜Ð¡ -
core +1 more source

Neurolupus [PDF]

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

Molecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha +6 more
wiley +1 more source

Novell ÑÐµ Ð·Ð´Ñ€ÑƒÐ¶ÑƒÐ²Ð° ÑÐ¾ lntel [PDF]

, 2016
Ð¸Ð·Ð²Ð°Ð ...
Ð¸Ð½Ñ„Ð¾Ñ€Ð¼Ð°Ñ‚Ð¸ÐºÐ°, ÐœÐ•Ð”Ð˜Ð¡ -
core +1 more source

Body Dysmorphic Disorder and Aesthetic Surgery [PDF]

, 2015
ÐžÐ¡ÐÐžÐ’Ð: Ð”Ð¸Ð·Ð¼Ð¾Ñ€Ñ„Ð¾Ñ„Ð¾Ð±Ð¸Ñ˜Ð°, Ð¸Ð»Ð¸ Ð½Ð° Ð°Ð½Ð³Ð»Ð¸ÑÐºÐ¸ Body Dismorphic Disorder (BDD)Â Ðµ Ñ€ÐµÐ»Ð°Ñ‚Ð¸Ð²Ð½Ð¾ Ñ‡ÐµÑÑ‚Ð¾ Ð¸ Ð¼Ð½Ð¾Ð³Ñƒ Ñ‚ÐµÑˆÐºÐ¾ Ð·Ð°Ð±Ð¾Ð»Ð¾Ð²Ð°ÑšÐµ ÐºÐ¾Ðµ Ð¼Ð½Ð¾Ð³Ñƒ Ð¿Ð°Ñ‚Ð¸ Ð¿Ð¾Ð¼Ð¸Ð½ÑƒÐ²Ð° Ð½ÐµÐ´Ð¸Ñ˜Ð°Ð³Ð½Ð¾ÑÑ‚Ð¸Ñ†Ð¸Ñ ...
Breshkovska, Hristina +3 more
core +2 more sources

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi +6 more
wiley +1 more source

, 2016
Ð¸Ð·Ð²Ð°Ð ...
Ð¸Ð½Ñ„Ð¾Ñ€Ð¼Ð°Ñ‚Ð¸ÐºÐ°, ÐœÐ•Ð”Ð˜Ð¡ -
core +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

Molecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke +12 more
wiley +1 more source

computer science
chemistry
mathematics

medicine
environmental chemistry
environmental science

combinatorics
internal medicine
political science